Anti-MRSA agent 7
Anti-MRSA agent 7 (Compound 12) is a potent antibacterial agent. Anti-MRSA agent 7 inhibits S. aureus DNA gyrase, E. coli DNA gyrase, S. aureus topo IV and E. coli topo IV with IC50s of 0.185, 0.365, 0.341 and 0.059 μM, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3049205-78-6
- Fòrmula: C22H20BrF2N3O4
- Peso molecular:508.31
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas DNA/RNA Synthesis
MoreVer todos los productos específicos de isoformas Topoisomerase
More
Actividad biológica
|
TOPO IV 0.059 μM (IC50, E. coli ) |
TOPO IV 0.341 μM (IC50, S. aureus) |
DNA gyrase 0.185 μM (IC50, S. aureus) |
DNA gyrase 0.365 μM (IC50, E. coli ) |
Anti-MRSA agent 7 (Compound 12) shows a dose-dependent killing efficacy achieving bactericidal effect against planktonic methicillin-resistant S. aureus (ATCC 43300) at 8 × MIC after 8 h of treatment, after which re-growth occurs[1].
Antimicrobial activity of Anti-MRSA agent 7 (Compound 12) against a panel of Gram-positive and Gram-negative bacterial pathogens[1]
| Strain | S. aureus (ATCC 29213) | MRSAQA-12.1 | E. coli N43 (CGSC# 5583) | MRSA QA-11.7 | MRSA QA-11.2 | E. faecalis DRK 057 | E. coli (ATCC 25922) |
| MIC (μM) | 0.03 | 0.03 | 0.06 | 0.06 | 0.124 | 4.07 | 252 |
| Strain | E. coli D22 | A. baumannii | E. coli ESBL QA:11.3 | K. pneumoniae | S. alachua RDK 030c | P. aeruginosa RDK 184 | |
| MIC (μM) | 252 | 252 | >252 | >252 | >252 | >252 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD-1 female mice, MRSA neutropenic mouse thigh infection model[1]
-
Dosage:20 and 40 mg/kg
-
Administration:IP/QID (four times a day) at 2, 8, 14, and 20 h post infection
-
Result:Demonstrated inhibition of bacterial growth in a dose dependent manner.
Chemical Information
-
No. CAS 3049205-78-6
-
Peso molecular 508.31
-
Fòrmula C22H20BrF2N3O4
-
SMILES
COC1=NC2=C(N=CC=C2OC[C@H]3CC[C@@H](CO3)NC(C4=CC(F)=C(C(F)=C4)Br)=O)C=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anti-MRSA agent 7 Related Classifications
HY-149271 Related Classifications
Powered by Bioz